By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


Company News
Clovis Oncology (CLVS) Enters into Clinical Trial Collaboration 8/11/2015 10:33:38 AM
Clovis Oncology (CLVS) Announces Second Quarter 2015 Operating Results 8/7/2015 7:31:47 AM
Clovis Oncology (CLVS) Completes U.S. And E.U. Regulatory Submissions For Rociletinib For The Treatment Of Advanced EGFR-Mutant T790M+ Non-Small Cell Lung Cancer 8/3/2015 11:09:16 AM
Clovis Oncology (CLVS) To Announce Second Quarter 2015 Financial Results And Host Webcast Conference Call On August 6 7/24/2015 11:01:38 AM
Clovis Oncology (CLVS) Announces Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock 7/10/2015 9:44:15 AM
Clovis Oncology (CLVS) Announces Pricing Of Public Offering Of Common Stock 7/9/2015 8:07:06 AM
Clovis Oncology (CLVS) Raising $275 Million to Develop Cancer Drug Pipeline 7/8/2015 6:21:27 AM
Clovis Oncology (CLVS) Initiates Rolling NDA Submission To The FDA For Rociletinib In The Treatment Of Advanced EGFR-Mutant Non-Small Cell Lung Cancer 7/2/2015 9:53:49 AM
Clovis Oncology (CLVS)’s CMO Quits Abruptly to Launch Own Immuno-Oncology Company 6/23/2015 8:31:58 AM
Clovis Oncology (CLVS) Appoints Dr. Lindsey Rolfe As Chief Medical Officer 6/22/2015 12:04:13 PM